Skip to Content

Notice

High Chemical Co. et al.; Proposal to Withdraw Approval of 13 New Drug Applications; Opportunity for a Hearing; Withdrawal

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 22054

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice; withdrawal.

SUMMARY:

The Food and Drug Administration (FDA) is withdrawing a notice that published in the Federal Register on January 28, 2005 (70 FR 4134). This notice is being reissued elsewhere in this issue of the Federal Register

DATES:

This notice is withdrawn on April 28, 2005.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Darlease Hyman, Regulations Policy Management Staff (HF-26), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-3480.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In the Federal Register of January 28, 2005 (70 FR 4134), FDA published a notice announcing an opportunity for a hearing on the agency's proposal to withdraw approval of 13 new drug applications from multiple sponsors. This notice published with an inadvertent error. Therefore, the agency is withdrawing the notice. Elsewhere in this issue of the Federal Register, FDA is reissuing the corrected notice for the convenience of the reader and to give sponsors the fully allotted time to respond.

Start Signature

Dated: April 5, 2005.

Jeffrey Shuren,

Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 05-8470 Filed 4-27-05; 8:45 am]

BILLING CODE 4160-01-S